Introduction
The production of bone marrow-derived hematopoietic cells is regulated by the availability of key cytokines, including IL-3 and GM-CSF. [1] [2] [3] The IL-3 ligand can provide a signal to proliferate as well as a signal promoting cell survival. Withdrawal of IL-3 from factor-dependent cells results in the induction of apoptosis, characterized by chromatin condensation, nucleolytic degradation of genomic DNA, and ultimately, loss of membrane integrity and cell viability. [4] [5] [6] [7] Despite the importance of this cell death process to hematopoietic homeostasis, relatively little is known about its molecular mechanism.
Several studies have indicated that IL-3-mediated suppression of apoptosis may involve protein kinase activities. Zha et al 8 have shown that IL-3 promotes phosphorylation of Bad, a binding partner and negative regulator of the antiapoptotic protein Bcl-2.
9,10 Phosphorylation of BAD results in the association of BAD with 14-3-3 protein. 8 This serves to free up Bcl-2 or other Bcl-2 family members to perform their function of suppressing apoptosis. Other studies indicate that protein kinase C (PKC) may be important in suppressing apoptosis in IL-3-dependent cell lines. Bryostatin, a PKC activator enhances the survival of IL-3-deprived FDCP-1 cells, while inhibitors of PKC abrogate the ability of IL-3 to suppress apoptosis. 11 Still further studies have shown that p53 plays an important role in IL-3 withdrawal-induced apoptosis. [12] [13] [14] Overexpression of wild-type p53 protein accelerates apoptosis in IL-3-deprived 32D cells, while overexpression of dominantnegative p53 mutants can protect IL-3-deprived 32D or DA-1 cells from death. 12, 13 In other systems of apoptosis, the involvement of caspase proteases has been well documented. Caspases are cysteine proteases which cleave substrate proteins after aspartate residues found in specific sequence contexts. [15] [16] [17] To date, at least 10 members of the caspase family have been identified (caspases-1 to -10). 17 In addition, several important caspase substrates have been identified, including PARP, a nuclear enzyme that is activated by DNA strand breaks and plays a role in DNA repair. [18] [19] [20] [21] [22] [23] Cleavage of substrate proteins such as PARP can be used to monitor caspase activation. Induction of apoptosis by stimulation of cell surface Fas antigen, [24] [25] [26] detachment of cells from extracellular matrix, 27 treatment with chemotherapeutic agents or radiation, [28] [29] [30] [31] [32] [33] or withdrawal of essential neurotrophic factor 34, 35 has been shown to activate cellular caspases. Strikingly, inhibition of caspase activities by peptide inhibitors or by cowpox virus CrmA protein generally inhibits loss of cell viability. 20, [24] [25] [26] [27] [28] [29] [30] 32, 34 This points to a crucial role for caspases in mediating apoptosis in a number of model systems.
The role of caspases in mediating apoptosis of factor-dependent hematopoietic cells has not been extensively investigated. Vasilakos et al, 36 using membrane-permeable peptide inhibitors, concluded that caspase-1 (ICE) is not required for apoptosis induced by IL-2 deprivation in an IL-2-dependent T cell line. More recently, Furlong et al 37 have shown that withdrawal of IL-3 from factor-dependent BAF3 cells, a murine pre-B cell line, results in the appearance of a 25 kDa PARP cleavage product. Intracellular acidification resulting from cytokine withdrawal was proposed as a mechanism to account for caspase activation and appearance of the 25 kDa PARP fragment. 37 Cleavage of PARP has also been detected following withdrawal of IL-3 from the Mo7e human megakaryoblastic cell line. 38 Finally, Barge et al 39 have shown that apoptosis in IL-3-deprived 32D cells can be blocked by z-VAD-FMK, but not by z-YVAD-FMK or z-DEVD-FMK. In the study reported here, we investigated the importance of caspase proteases during IL-3 withdrawal-induced apoptosis in 32D and FDCP-1 cells, two IL-3-dependent myeloid progenitor cell lines. We found that IL-3 withdrawal led to caspase activation and cleavage of PARP protein in both cell lines. Moreover, the caspase(s) activated by IL-3 withdrawal exhibited a unique profile of inhibition when compared with caspases activated by other apoptotic stimuli.
Materials and methods

Cell culture
Murine 32D (clone 23) cells 40, 41 and murine FDCP-1 cells 4 were grown in complete media, defined as RPMI 1640 con-taining 10% fetal bovine serum (FBS), 10% WEHI-3B cell conditioned media, 1 ng/ml recombinant murine IL-3 (Upstate Biotechnology, Lake Placid, NY, USA), 0.3 mg/ml L-glutamine (glut), 50 units/ml penicillin (pen), and 50 g/ml streptomycin sulfate (strep). Jurkat T leukemic cells were grown in RPMI 1640 media containing 10% heat-inactivated FBS and glut/pen/strep. Media for transfected 32D and Jurkat cell lines were supplemented with 0.5 mg/ml G418 (Gibco BRL, Gaithersburg, MD, USA) at all times. All cells were maintained in an humidified incubator at 37°C and 5% CO 2 .
Apoptosis inducation and cell viabilities
For IL-3 withdrawal experiments, cells were first plated at a density of 3 × 10 5 cells/ml in complete media containing 1 ng/ml recombinant IL-3, and allowed to grow for 24 h at 37°C. Following this preincubation, cells were centrifuged and washed a total of five times in cold phosphate-buffered saline (PBS). After the final wash, cells were plated at a density of 1 × 10 6 cells/ml in RPMI 1640 media containing 10% FBS and glut/pen/strep. Cells were then placed at 37°C, and at various timepoints thereafter, aliquots were removed for preparation of whole cell lysates or genomic DNA. The resuspension of cells in IL-3-deficient media was defined as t = 0.
For induction of Fas-mediated apoptosis, Jurkat cell lines were plated at 5 × 10 6 cells/ml in RPMI 1640 containing 10% FBS and glut/pen/strep. Anti-Fas antibody (Upstate Biotechnology), diluted in PBS, was then added to a final concentration of 200 ng/ml and the cells were placed at 37°C. At various timepoints thereafter, aliquots were removed for preparation of cell lysates.
Cell viabilities were assessed by trypan blue exclusion. For each datapoint a minimum of 100 cells were analyzed. All assays were repeated in triplicate.
In vitro cleavage of 35 S-PARP Cells were pelleted, washed four times in cold PBS, and resuspended in 10 mM Hepes (pH 7.4), 1 mM EDTA, 0.1% CHAPS, 5 mM DTT, 1 mM PMSF, 2 g/ml leupeptin, 1 g/ml aprotinin, 10 g/ml pepstatin A. Following a 10 min incubation on ice, the resuspended cells were lysed using a type B dounce homogenizer. The cytosolic extracts were then clarified by sequential microcentrifugation for 5 and 30 min, respectively. Cleavage assays using in vitro translated 35 S-PARP were performed as previously described. 32 Briefly, 3 l of 35 S-PARP was incubated with cytosolic extract for 2 h at 30°C in 50 l reaction volumes of 20 mM Hepes (pH 7.4), 10% glycerol, 2 mM DTT. Experiments with extracts prepared from IL-3-deprived cells used 0.5 g of cytosolic extract per reaction, while experiments with anti-Fas-treated cells used 4 g of cytosolic extract. The cytosolic extracts were prepared after depriving cells of IL-3 for 30 (32D) or 28 (FDCP-1) h. At these timepoints, endogenous PARP was fully cleaved. Reaction products were electrophoresed on 12.5% SDS/PAGE gels, transferred to nitrocellulose membranes, and subjected to autoradiography.
Peptides z-VAD-FMK and z-DEVD-FMK (Kamiya Biomedical Company, Tukwila, WA, USA) were dissolved and diluted in DMSO. For peptide inhibition experiments, 1l of a 50 × peptide stock was added to in vitro cleavage assays prior to the addition of 35 S-PARP. In control reactions, 1 l of DMSO alone was added.
Western blotting
For Western blotting experiments, cells were pelleted, washed once in cold PBS, and then lysed in 50 mM Tris (pH 8.0), 150 mM NaCl, 0.1% SDS, 1.0% NP-40, 1.5 mM PMSF, 3 g/ml leupeptin, 20 g/ml aprotinin. A Bio-Rad (Hercules, CA, USA) protein assay kit was used to determine protein concentrations in the lysates. Twenty-five microgram aliquots of protein samples were electrophoresed on 12.5% SDS/PAGE gels, then transferred to nitrocellulose membranes. Membranes were incubated at room temperature for 1 h in blocking solution (PBS, 0.05% Tween-20, 5% nonfat dry milk), washed twice in PBST (PBS, 0.05% Tween-20), then incubated with primary antibody for 1 h at room temperature in PBSTB (PBST containing 1% bovine serum albumin). Anti-PARP monoclonal antibody (Pharmingen, San Diego, CA, USA) was used at a 1:2000 dilution. This monoclonal antibody recognizes intact PARP protein, as well as the 85 kDa proteolytic fragment of PARP. Following incubation with primary antibody, membranes were washed five times in PBST, then incubated with a 1:2500 dilution of horse-radish peroxidase-conjugated goat anti-mouse antibody (Promega, Madison, WI, USA) for 1 h at room temperature in PBSTB. Membranes were then washed five times in PBST and developed using an enhanced chemiluminescence kit from Amersham (Arlington Heights, IL, USA), according to the instructions of the manufacturer. It should be noted that low levels of PARP cleavage were often seen in unstimulated cells, perhaps due to cleavage during the harvest procedure (see Figure 1 ).
Establishment of transfected cell lines
The CrmA and Bcl-2 proteins were expressed in cells as epitope-tagged proteins, with the 11-amino acid KT3 epitope tag 42 fused to the carboxyl termini of the proteins. 43 A description is provided elsewhere of the mammalian expression vectors which utilized a cytomegalovirus promoter to drive expression of the CrmA-KT3 or Bcl-2-KT3 fusion cDNAs. 43 To generate stable 32D cell lines expressing epitope-tagged CrmA or Bcl-2 proteins, cells were electroporated (250V, 960F) with 15 g of the CMV/neo/CrmA-KT3 or CMV/neo/Bcl-2-KT3 expression constructs. 43 As a control, 32D cells were also electroporated with the CMV/neo vector alone. Electroporated cells were allowed to recover for 2 days in media lacking G418, followed by addition of G418 to 0.5 mg/ml. After 2 weeks of selection in G418, independent clonal cell lines were isolated by limiting dilution and then analyzed for expression of the desired protein by Western blotting with an anti-KT3 monoclonal antibody. A clonal 32D cell line overexpressing the BCR/ABL protein was kindly provided by Dr U Matulonis. 44 The isolation of transfected Jurkat cell lines expressing CrmA-KT3 or Bcl-2-KT3 is described elsewhere. 43 Preparation of genomic DNA At various times after IL-3 withdrawal, aliquots of cells were harvested for preparation of genomic DNA. For early timepoints (t = 0 to t = 18 h) 1 × 10 6 cells were harvested, and for later timepoints up to 4 × 10 6 cells were harvested. Cells were pelleted, washed once in cold PBS, and lysed in 400 l of 10 mM Tris (pH 8.0), 100 mM NaCl, 25 mM EDTA, 0.5% SDS, 200 g/ml proteinase K. The lysed cells were incubated for 6-8 h at 50°C, followed by sequential extractions with phenol/T 10 E 1 , phenol/CHCl 3 and CHC1 3 . The extracted DNA was precipitated overnight, pelleted, washed once with 1.0 ml of 70% ethanol, dried, then resuspended in 500 l of T 10 E 1 containing 50 g/ml RNase A. RNase digestion was allowed to proceed for 2 h at 37°C, followed again by sequential extractions of the DNA. The extracted DNA was once again precipitated, pelleted, washed, dried, and then resuspended in 40 l of T 10 E 1 buffer. DNA samples (5 g/lane) were electrophoresed on 2% agarose gels and stained with ethidium bromide.
Results
Activation of PARP cleavage by IL-3 withdrawal
The myeloid progenitor cell lines 32D and FDCP-1 are dependent on IL-3. 4, 40, 41 Withdrawal of IL-3 from these cells leads to apoptosis. To determine whether caspase-like proteases are activated during IL-3 withdrawal-induced apoptosis, we asked whether intracellular PARP protein was cleaved during the death process. The PARP enzyme is known to catalyze ADPribosylation of nuclear proteins in response to DNA strand breaks, thereby promoting repair of damaged DNA.
21-23 During apoptosis triggered by chemotherapy, 18 Fas stimulation, 19, 20 or cell confluency, 45 PARP is cleaved to characteristic 85 kDa and 24 kDa fragments. In these systems, cleavage of PARP is known to be mediated by caspase proteases. As shown in Figure 1 drawal (Figure 1a and b, lanes 4) . Complete cleavage was seen after 24 h of IL-3 deprivation (Figure 1a and b, lanes 6 ).
To determine whether PARP cleavage was directly associated with apoptosis induced by IL-3 withdrawal, we examined PARP cleavage in 32D cells overexpressing the BCR/ABL oncoprotein ( Figure 1a, lanes 8-11) . BCR/ABL/32D cells do not depend on exogenous IL-3 for survival. 44 Relatively little PARP cleavage was seen in the IL-3-deprived BCR/ABL/32D cells, even after 48 h (Figure 1a, lanes 9-11) . This result indicates that the PARP cleavage we observed in untransfected 32D and FDCP-1 cells was associated with IL-3 withdrawalinduced apoptosis and not some unrelated aspect of IL-3 signaling.
In Figure 1c , genomic DNA was analyzed from aliquots of the IL-3-deprived cells shown in Figure 1a 
Inhibition of PARP cleavage by caspase protease inhibitors
To characterize the protease responsible for PARP cleavage in IL-3-deprived cells, we examined the effects of two peptide inhibitors of caspase proteases, z-VAD-FMK and z-DEVD-FMK. The z-VAD-FMK peptide is based on the known cas-pase-1 cleavage site in pro-IL-1␤ protein, while z-DEVD-FMK is based on the caspase-3 (CPP32) cleavage site in PARP protein. 19, 46 However, both peptides may inhibit, to varying degrees, other members of the caspase protease family. 47 Cytosolic extracts were prepared from IL-3-deprived 32D and FDCP-1 cells, and the extracts were assayed for their ability to cleave in vitro translated 35 S-PARP in the presence or absence of varying concentrations of peptide inhibitors (Figure 2a and b) . As a control, lysates were prepared and tested from Jurkat T leukemic cells treated with agonistic antiFas antibody (Figure 2c) . PARP cleavage and apoptosis induced by Fas stimulation are known to be mediated by a cascade of caspase proteases. [24] [25] [26] 48, 49 As depicted in Figure 2 , both z-DEVD-FMK and z-VAD-FMK effectively inhibited PARP cleavage activities in extracts of IL-3-deprived 32D and FDCP-1 cells. For 32D extracts, inhibition of PARP cleavage activity was first detected at concentrations of 0.1 M for both z-DEVD-FMK and z-VAD-FMK (Figure 2a, lanes 5 and 11) . More substantial partial inhibition was seen at 1.0 M concentrations (lanes 6 and 12), and near maximal inhibition at 10 M (lanes 7 and 13) . This inhibition profile closely resembled the inhibition profile seen in extracts from Fas-stimulated Jurkat cells (Figure 2c ). In FDCP-1 extracts, the peptide inhibitors were somewhat less potent at blocking PARP cleavage activity (Figure 2b ). In this case, inhibition was first detected at 1.0 M z-DEVD-FMK or z-VAD-FMK (lanes 6 and 12), while more significant partial inhibition was seen at 10 M (lanes 7 and 13) and near maximal inhibition required 50 M concentrations (lanes 8 and 14) . Since z-DEVD-FMK and z-VAD-FMK are specific inhibitors of caspase proteases, the studies presented in Figure 2 indicate that the cleavage of PARP following IL-3 withdrawal is mediated by a caspase protease. However, it remains undetermined which caspase family member is activated and is responsible for cleaving PARP following IL-3 deprivation.
Recently, Furlong et al 37 PARP cleavage, DNA fragmentation, and loss of cell viability accompanying IL-3 withdrawal are blocked by Bcl-2, but not CrmA
To further characterize the PARP cleavage activity induced by IL-3 withdrawal, we examined the effects of two known inhibitors of PARP cleavage and apoptosis, the Bcl-2 and CrmA proteins. Bcl-2 is a potent inhibitor of apoptosis, including apoptosis induced by IL-3 withdrawal. 9, 10 In addition, Bcl-2 has been shown to block PARP cleavage, by an unknown mechanism, in cells treated with staurosporine, 50 ceramide, 51 or anti-Fas antibodies. 52 CrmA is a potent inhibitor of apoptosis resulting from Fas stimulation, 20,24-26 neurotrophic factor withdrawal, 34 and detachment from the extracellular matrix. 27 CrmA exerts its effects by binding to and directly inhibiting caspase proteases. [53] [54] [55] To study the effects of Bcl-2 and CrmA on IL-3 withdrawalinduced PARP cleavage and apoptosis, we utilized 32D cells engineered to overexpress either protein. Both proteins were expressed as epitope-tagged proteins, using an 11-amino acid epitope tag (KT3) 42 attached to their carboxyl termini. Figure 3 shows an anti-KT3 immunoblot of two clones of vector-transfected 32D cells (Vector/32D), two clones of 32D cells expressing the CrmA-KT3 protein (CrmA/32D), and one clone expressing the Bcl-2-KT3 protein (Bcl-2/32D).
In Figure 4a , transfected 32D cells were deprived of IL-3 for 24 h, followed by anti-PARP immunoblot analysis of whole cell lysates. As expected, essentially complete cleavage of PARP was seen in the IL-3-deprived Vector/32D cells (lanes 2 and 4). Cleavage of PARP was completely blocked by overexpression of Bcl-2-KT3 (lane 10). A similar effect of Bcl-2-KT3 was seen in control experiments using a Bcl-2-KT3-expressing Jurkat cell line that was treated with anti-Fas (Figure 4b, lanes 5 and 6) . Overexpression of CrmA-KT3, in contrast to Bcl-2-KT3, failed to inhibit PARP cleavage in IL-3-deprived CrmA/32D cell lines (Figure 4a, lanes 6 and 8) . The failure of CrmA-KT3 to inhibit IL-3 withdrawal-induced PARP cleavage was not due to a functional defect in the epitopetagged fusion protein, since overexpression of CrmA-KT3 was able to block PARP cleavage in an anti-Fas treated Jurkat cell line (Figure 4b, lanes 3 and 4) . Thus, it appears that the caspase(s) mediating IL-3 withdrawal-induced PARP cleavage is CrmA-insensitive.
The effect of CrmA on fragmentation of genomic DNA, an important marker of apoptosis, was examined in Figure 5 . DNA was analyzed from aliquots of the cells depicted in Figure 4a . Fragmentation of DNA to oligonucleosomal-length fragments was observed in IL-3-deprived Vector/32D cell lines ( Figure 5, lanes 2 and 4) and was effectively blocked by expression of Bcl-2-KT3 (lane 10). However, as with PARP cleavage, expression of CrmA-KT3 failed to block DNA fragmentation (lanes 6 and 8) .
Finally, the ability of CrmA to prevent loss of cell viability following IL-3 withdrawal was tested in Figure 6 . CrmA/32D cell lines exhibited loss of cell viability indistinguishable from that displayed by Vector/32D cells. A similar effect of CrmA on cell viability has been reported by Barge et al. 39 Therefore, in the case of CrmA, failure to prevent IL-3 withdrawalinduced caspase activity correlated with a failure to inhibit apoptosis. On the other hand, Bcl-2/32D cells were protected from loss of viability following IL-3 withdrawal, in agreement with the findings of others. 9, 10 Thus, in the case of Bcl-2, efficient inhibition of caspase activity correlated with an ability to prevent apoptosis.
Discussion
In this study we have examined cellular signaling events that are activated during apoptosis in IL-3-deprived myeloid progenitor cell lines. We have determined that IL-3 withdrawal leads to induction of PARP cleavage, beginning roughly 12 h after withdrawal, and reaching completion after 24 h. The induced PARP cleavage activities are inhibited by two caspase protease inhibitors, z-DEVD-FMK and z-VAD-FMK, indicating that a caspase protease mediates the observed cleavage. Expression of Bcl-2, but not CrmA, blocked IL-3 withdrawalinduced PARP cleavage.
IL-3 promotes both the proliferation and the survival of bone marrow-derived factor-dependent cells. In BAF3 cells, the tyrosine kinase inhibitor genistein has been shown to inhibit IL-3-induced DNA synthesis, but not IL-3-mediated suppression of apoptosis. 56 This indicates that distinct intracellular pathways are utilized by the IL-3-activated proliferation and survival signals. To date, relatively little is known about the mechanism of IL-3-mediated suppression of cell death. Conversely, little is known about the intracellular signaling events that facilitate apoptosis in the absence of IL-3. Our results show that removal of IL-3 activates a protease(s) in the caspase protease family, leading to the cleavage of intracellular substrate proteins. It remains undetermined whether a single caspase is activated, or, as is the case in Fasmediated apoptosis, 48, 49 a cascade of caspases is activated. Accumulated cleavage of intracellular proteins may ultimately lead to the demise of the cell.
The cleavage of cellular PARP has been observed in response to a variety of other apoptotic stimuli. For example,
Figure 5
CrmA fails to inhibit fragmentation of genomic DNA in IL-3-deprived 32D cells. Genomic DNA was isolated from aliquots of transfected 32D cells grown in the presence of 1 ng/ml recombinant IL-3 or deprived of IL-3 for 24 h (depicted in Figure 4a ). DNA samples (5 g/lane) were analyzed on a 2% agarose gel.
in analogous systems, withdrawal of nerve growth factor from chick dorsal root ganglia cells or neuronally-differentiated PC12 cells leads to caspase protease activation and PARP cleavage. 34, 35 Expression of CrmA protein has been shown to block apoptosis in the nerve growth factor-deprived ganglia cells. 34 Expression of CrmA can also inhibit apoptosis caused by stimulation of Fas or tumor necrosis factor receptor, 20, [24] [25] [26] treatment with chemotherapy drugs, 32 or detachment from extracellular matrix. 27 Strikingly, we found that CrmA failed to prevent IL-3 withdrawal-induced PARP cleavage, DNA fragmentation, and loss of cell viability. These findings indicate that the apoptotic signaling pathways induced by cytokine withdrawal are to some degree distinct from those induced by other stimuli. Thus, although they may share some common components, it is likely that apoptotic Viability of the transfected 32D cells following Il-3 withdrawal. IL-3 was withdrawn from the transfected 32D cells as described in Materials and methods. At various timepoints after IL-3 removal, cell viabilities were assessed by trypan blue exclusion. Data points represent the mean of triplicate samples, with a minimum of 100 cells analyzed for each sample. Error bars indicate the standard deviations. While expression of Bcl-2 conferred a significant survival advantage, expression of CrmA had no effect on survival.
pathways initiated by cytokine withdrawal in myeloid precursors differ from apoptotic pathways induced by neurotrophic factor withdrawal in neuronal cells.
The failure of CrmA to inhibit IL-3 withdrawal-induced PARP cleavage may provide a clue regarding the identity of the caspases that are activated in myeloid progenitors. Several studies have shown that CrmA protein differentially inhibits different members of the caspase protease family. 45, 49, 57 Most recently, Zhou et al 57 have shown that CrmA potently inhibits caspase-1 (ICE; K i = Ͻ0.01 nmol/l), moderately inhibits caspase-8 (MACH/FLICE; K i = 0.95 nmol/l); and poorly inhibits caspase-3 (CPP32/Yama; K i = 0.5 mol/l), caspase-6 (Mch2; K i = 0.11 mol/l); and caspase-7 (LAP3; K i = Ͼ40 mol/l). These results suggest that caspase-1 and caspase-8 are not responsible for PARP cleavage in the IL-3-deprived myeloid progenitor cell lines. Consistent with this, we have failed to detect expression of caspase-1 in either 32D or FDCP-1 cells using Western blotting (unpublished observations). We have also failed to detect expression of caspase-3. This is interesting, since caspase-3 is thought to be the major protease responsible for PARP cleavage during Fas-mediated apoptosis. 20, 49 On the other hand, we have detected abundant expression of caspase-2 protein in both cell lines (unpublished observations). In agreement with this, Kumar 58 has observed expression of caspase-2 mRNA in FDCP-1 cells. Moreover, antisense to caspase-2 mRNA resulted in a modest enhancement of FDCP-1 cell survival following IL-3 withdrawal. 58 Thus, caspase-2 may play a role in the apoptotic death of IL-3-deprived myeloid progenitors.
In conclusion, we have demonstrated that IL-3 withdrawal induces caspase protease activity in factor-dependent myeloid precursor cell lines. The failure of CrmA to inhibit this activity indicates that differences exist between the caspase(s) activated by IL-3 withdrawal and those activated by other apoptotic stimuli. Additional studies will begin to shed light on which caspases are activated by IL-3 withdrawal, and how the activation of these caspases may lead to apoptotic commitment in myeloid progenitors.
